TOWA Pharmaceutical Co (FRA:6QC) Cyclically Adjusted Book per Share: €14.35 (As of Mar. 2026)


FRA:6QC TOWA Pharmaceutical Co Ltd FRA:6QC
88 GF Score
Price €21.60
GF Value €18.12
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is TOWA Pharmaceutical Co Cyclically Adjusted Book per Share?

TOWA Pharmaceutical Co FRA:6QC 88 Cyclically Adjusted Book per Share is €14.35 as of Mar. 2026. GuruFocus rates FRA:6QC with a GF Score™ of 88/100 and a GF Value™ of €18.12 (Modestly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

TOWA Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was €19.722. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €14.35 for the trailing ten years ended in Mar. 2026.

During the past 12 months, TOWA Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 10.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 11.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 12.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of TOWA Pharmaceutical Co was 12.50% per year. The lowest was 8.90% per year. And the median was 11.30% per year.

As of today (2026-07-09), TOWA Pharmaceutical Co's current stock price is €21.60. TOWA Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €14.35. TOWA Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.51.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of TOWA Pharmaceutical Co was 2.51. The lowest was 0.88. And the median was 1.50.


TOWA Pharmaceutical Co  (FRA:6QC) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

TOWA Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=21.60/14.35
=1.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of TOWA Pharmaceutical Co was 2.51. The lowest was 0.88. And the median was 1.50.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


TOWA Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


TOWA Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for TOWA Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TOWA Pharmaceutical Co Cyclically Adjusted Book per Share Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.37 13.15 13.28 14.62 14.35

TOWA Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.62 14.34 14.19 13.96 14.35

FRA:6QC vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOWA Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


FRA:6QC
88GF Score
TOWA Pharmaceutical Co Ltd FRA:6QC
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TOWA Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TOWA Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=19.722/112.7000*112.7000
=19.722

Current CPI (Mar. 2026) = 112.7000.

TOWA Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 11.814 98.100 13.572
201609 12.462 98.000 14.331
201612 12.303 98.400 14.091
201703 12.611 98.100 14.488
201706 12.422 98.500 14.213
201709 12.079 98.800 13.778
201712 12.283 99.400 13.927
201803 12.420 99.200 14.110
201806 13.066 99.200 14.844
201809 13.251 99.900 14.949
201812 14.130 99.700 15.972
201903 14.849 99.700 16.785
201906 15.737 99.800 17.771
201909 16.791 100.100 18.905
201912 16.887 100.500 18.937
202003 17.876 100.300 20.086
202006 17.770 99.900 20.047
202009 17.813 99.900 20.095
202012 17.981 99.300 20.407
202103 18.308 99.900 20.654
202106 18.704 99.500 21.185
202109 19.819 100.100 22.314
202112 20.641 100.100 23.239
202203 20.561 101.100 22.920
202206 19.266 101.800 21.329
202209 19.868 103.100 21.718
202212 19.581 104.100 21.199
202303 19.434 104.400 20.979
202306 19.102 105.200 20.464
202309 18.909 106.200 20.066
202312 19.257 106.800 20.321
202403 19.449 107.200 20.447
202406 19.488 108.200 20.298
202409 20.371 108.900 21.082
202412 21.318 110.700 21.703
202503 21.635 111.100 21.947
202506 21.054 111.700 21.242
202509 21.053 112.000 21.185
202512 21.106 113.000 21.050
202603 19.722 112.700 19.722

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €14.35 mean?
TOWA Pharmaceutical Co (FRA:6QC) has a Cyclically Adjusted Book per Share of €14.35 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on TOWA Pharmaceutical Co and its competitors.
Is TOWA Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
TOWA Pharmaceutical Co's current Cyclically Adjusted Book per Share is €14.35. Overall, TOWA Pharmaceutical Co has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TOWA Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
TOWA Pharmaceutical Co's Cyclically Adjusted Book per Share of €14.35 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on TOWA Pharmaceutical Co and its competitors. TOWA Pharmaceutical Co's current Cyclically Adjusted Book per Share is €14.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TOWA Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, TOWA Pharmaceutical Co (FRA:6QC) is currently considered Modestly Overvalued. The stock's GF Value™ is €18.12, compared to a current price of €21.60 — trading 19.2% above its estimated fair value. The current Cyclically Adjusted Book per Share is €14.35. TOWA Pharmaceutical Co's overall GF Score™ is 88/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For TOWA Pharmaceutical Co (FRA:6QC), the current Cyclically Adjusted Book per Share is €14.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TOWA Pharmaceutical Co (FRA:6QC) Overvalued in 2026?

Based on GuruFocus' analysis, TOWA Pharmaceutical Co stock appears to be overvalued. The current stock price of €21.60 is trading 19.2% above its estimated GF Value™ of €18.12. GuruFocus considers TOWA Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for FRA:6QC:

  • Cyclically Adjusted Book per Share: €14.35
  • GF Value™: €18.12 vs. price of €21.60 (19.2% above fair value)
  • GF Score™: 88/100 with 7 warning signs

No single metric tells the full story. See the FRA:6QC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TOWA Pharmaceutical Co Business Description

Other Exchanges 4553:Japan
Address 2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
88GF Score

Get the complete analysis for FRA:6QC

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.60
Price
€18.12
GF Value